Cat. No. 2677
Chemical Name: 7-Amino-4-chloro-3-methoxy-1H-2-benzopyran
Biological ActivityInhibitor of γ-secretase that selectively inhibits βAPP cleavage without affecting other γ-secretase-mediated pathways. Prevents recovery of Aβ40 and Aβ42 from HEK293 cell overexpressing wild-type or Swedish-mutated βAPP (IC50 ~ 30 μM) but displays no effect on Notch cleavage and Notch-mediated intracellular signaling. Displays no activity on BACE1, BACE2, α-secretase, the proteosome or GSK3β.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Petit et al (2001) New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage. Nat.Cell.Biol. 3 507. PMID: 11331880.
Petit et al (2003) JLK isocoumarin inhibitors: selective γ-secretase inhibitors that do not interfere with Notch pathway in vitro or in vivo. J.Neurosci.Res. 74 370. PMID: 14598313.
Hellstrom et al (2007) DII4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445 776. PMID: 17259973.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: JLK 6, supplier, inhibitors, γ-secretase, gamma-secretase, mediated, βAPP, betaAPP, processing, Proteinases, Proteases, β-Amyloid, beta-Amyloid, b-amyloid, Precursor, Protein, APP, beta, Peptides, JLK6
Find multiple products by catalog number
New Products in this Area
Dipeptidyl peptidase II (DPP-II) inhibitorVialinin A
Inhibitor of USP4 and USP5/IsoTMI 2 (MALT1 inhibitor)
MALT1 inhibitorNSC 687852
Inhibitor UCHL5 and USP14GI 254023X
Selective ADAM10 metalloprotease inhibitorGM 6001
Broad-spectrum MMP inhibitorNSC 405020
Inhibitor of MT1-MMP; antitumor
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.